# Phase 4 Human Confirmation

Status: ON HOLD — HUMAN CONFIRMATION REMAINS PENDING

Prepared: 2026-07-16

Checklist gate: `P4-45`

## Purpose

Confirm that the completed Phase 4 Runtime Hardening result is acceptable to a
human reviewer before the phase closes. This confirmation does not authorize
publication, distribution, deployment, or dependency release.

Phase 4 was previously closed from automated evidence. It was explicitly
reopened to add this human gate. All earlier checklist items remain complete;
only human acceptance is pending.

## Review Artifacts

Primary evidence:

- `docs/phase/phase-4.md`: scope, constraints, verification evidence, residual
  warnings, and Stage 4.6 status;
- `docs/phase/phase-4-checklist.md`: authoritative P4-01 through P4-45 ledger;
- `docs/phase/phase-4-publish-readiness.md`: artifact identity, dependency and
  ABI state, residual warnings, release order, and explicit `not
  publish-ready` result;
- `docs/spec/source-authentication.md`: credential-reference and redaction
  contract;
- `docs/spec/information-source-refresh.md` and
  `docs/spec/catalog-cache-policy.md`: bounded refresh, retry, concurrency,
  retention, and last-known-good behavior;
- `docs/spec/runtime-compatibility-matrix.md` and
  `docs/spec/car-abi-governance.md`: runtime and ABI compatibility policy; and
- `docs/spec/phase-4-executable-coverage.json`: behavioral checklist-to-test
  and scripted-gate mapping.

Recorded automated evidence includes:

- CBD Support: 116 tests across 16 suites;
- SIE: 81 tests across 11 suites;
- CBD and SIE CML lint and normal CAR lint;
- CBD/SIE SAR runtime profiles with exact read-tool counts `6/7`, `0/0`,
  `6/0`, and `5/6`;
- source-aware composed retrieval and runtime compatibility execution; and
- a built `0.1.0-SNAPSHOT` CBD Support CAR with recorded descriptor, ABI,
  size, and SHA-256 evidence.

## Residual State

- The public-release result is `not publish-ready`.
- CBD Support and its required CNCF coordinate remain SNAPSHOTs.
- The first-release ABI baseline is correctly pending until a real release.
- CBD CAR lint retains the documented `abi.baseline.missing` warning.
- SIE CAR lint retains its existing missing ABI manifest warning.
- Publication remains a separate explicitly authorized workflow.

## Human Acceptance Criteria

Confirm all of the following:

1. Phase 4's authentication and secret-handling boundary is acceptable.
2. Refresh, retry, cache, concurrency, and stale-evidence behavior is
   sufficiently bounded and observable.
3. CBD/SIE SAR composition and MCP ownership behavior is acceptable.
4. Runtime, ABI, Catalog, BoK, SIE, and local-CAR compatibility decisions are
   sufficiently explicit and fail closed where required.
5. README, user guide, reference manual, phase record, and static contracts are
   sufficient for the implemented runtime-hardening behavior.
6. The residual warnings and the `not publish-ready` conclusion are acceptable
   for Phase 4 closure.
7. Closing Phase 4 without publishing is acceptable, and publication remains a
   separate future authorization.

## Required Human Response

To accept, respond explicitly with either:

```text
Phase 4 human confirmation complete.
```

or another unambiguous statement accepting Stage 4.6 and P4-45.

To reject or request changes, identify the acceptance criterion and required
correction. P4-45 remains unchecked while corrections are implemented and
validated.

After acceptance, invoke `cncf-goal-phase` for Phase 4 again. The workflow will
record the human confirmation, complete P4-45, perform final stabilization, and
close the phase if no other closure condition remains.

## Deferral Record

On 2026-07-16, the human reviewer stated that P4-45 could not be completed for
some time and directed development to continue beyond the gate. P4-45 remains
unchecked. Phase 5 may proceed independently, but its progress cannot be used
as evidence of Phase 4 human acceptance and does not authorize publication.

## Confirmation Record

Pending explicit human confirmation; currently on hold.
